Paper

Tree Display

AceDB Schema

XML Display

Feedback

Paper Report for: Li_2022_Drug.Des.Devel.Ther_16_3557

Reference

Title: Semaglutide May Alleviate Hepatic Steatosis in T2DM Combined with NFALD Mice via miR-5120/ABHD6
Li R, Ye Z, She D, Fang P, Zong G, Hu K, Kong D, Xu W, Li L and Xue Y <2 more author(s)>
Ref: Drug Des Devel Ther, 16:3557, 2022 : PubMed

        



Related information



Citations formats

Li R, Ye Z, She D, Fang P, Zong G, Hu K, Kong D, Xu W, Li L, Zhou Y, Zhang K, Xue Y (2022)
Semaglutide May Alleviate Hepatic Steatosis in T2DM Combined with NFALD Mice via miR-5120/ABHD6
Drug Des Devel Ther 16: 3557-3572

Li R, Ye Z, She D, Fang P, Zong G, Hu K, Kong D, Xu W, Li L, Zhou Y, Zhang K, Xue Y (2022)
Drug Des Devel Ther 16: 3557-3572



Send your questions or comments to :
Mail to: Nicolas Lenfant, Thierry Hotelier, Yves Bourne, Pascale Marchot and Arnaud Chatonnet.
Please cite: Lenfant 2013 Nucleic.Acids.Res. or Marchot Chatonnet 2012 Prot.Pept Lett.
For technical information about these pages see:
ESTHER Home Page and ACEDB Home Page
AcePerl Lincoln Stein Home Page
webmaster

Acknowledgements and disclaimer